REXULTI® (brexpiprazole) Patient Information Website
Por um escritor misterioso
Descrição
Rexulti Approved by FDA for Major Depressive Disorder and Schizophrenia
JAMA Neurology Publishes Complete Results of Positive Phase 3 Study of REXULTI® (brexpiprazole) for Agitation Associated with Dementia Due to Alzheimer's Disease
Rexulti.PDF
brexpiprazole
Brexpiprazole Warnings: Side Effects of Rexulti
What you need to know about Rexulti (Brexpiprazole)
Brexpiprazole: mechanism of action, pharmacokinetics, application and side effect_Chemicalbook
Otsuka, Lundbeck's sNDA for Rexulti received US FDA approval
Effects of Brexpiprazole on Functioning in Patients With Schizophrenia: Post Hoc Analysis of Short- and Long-Term Studies
Brexpiprazole Updated - Gateway Psychiatric
Rexulti (Brexpiprazole) for the Treatment of Major Depressive Disorder (MDD) and Schizophrenia - Clinical Trials Arena
de
por adulto (o preço varia de acordo com o tamanho do grupo)
